Abstract
AbstractINTRODUCTIONApolipoprotein (APOE) ε4 and subjective cognitive decline (SCD) increase risk of Alzheimer’s disease. However, few studies have examined the relationship between SCD and APOE, especially using longitudinal data. The current study examined whether APOE is associated with the rate of cognitive change in SCD.METHODSLinear mixed effects models examined the relationship between APOE status and cognitive change in older adults with SCD (SCD), normal controls (NC), and people with mild cognitive impairment (MCI).RESULTSThe presence of at least one ε2 allele in SCD and MCI results in cognitive change rates similar to a NC with the ε3ε3 genotype. Older SCD-ε4 individuals exhibited increased cognitive decline compared to all groups, including NC-ε4 and MCI-ε4.DISCUSSIONPeople with SCD with at least one ε4 allele will experience increased cognitive decline compared to cognitively healthy older adults and people with MCI. These findings have important implications for treatments and interventions.
Publisher
Cold Spring Harbor Laboratory
Reference30 articles.
1. Zeisel J , Bennett K , Fleming R . Zeisel, J ., Bennett, K. , & Fleming, R. (2020). World Alzheimer Report 2020: Design, Dignity, Dementia: Dementia-Related Design and the Built Environment.; 2020.
2. Petersen RC . Mild Cognitive Impairment. Contin Lifelong Learn Neurol. 2016;22(2). Accessed June 5, 2016. http://www.alz.org/dementia/downloads/topicsheet_MCI.pdf
3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
4. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families